Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Tumori|December 31, 1990
Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2M Squadrelli-Saraceno, L Rivoltini, G Cantù, et al.
Haematologica|January 1, 1990
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF)S Siena, M Bregni, F Ravagnani, et al.
Tumori|October 31, 1988
A new procedure for large scale production and freezing of lymphokine activated killer (LAK) cells to be used in adoptive immunotherapy of cancerC Gambacorti-Passerini, M Radrizzani, L Rivoltini, et al.
British Journal of Haematology|September 1, 1996
Combined negative and positive selection of mobilized CD34 blood cellsM Di Nicola, M Bregni, S Siena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigensC Castelli, P Tarsini, A Mazzocchi, et al.
Haematologica|May 9, 1998
Mobilized peripheral blood CD34+ cells express more amphotropic retrovirus receptor than bone marrow CD34+ cellsM Bregni, M Di Nicola, S Siena, et al.
Hematological Oncology|March 1, 1989
Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?A M Gianni, M Bregni, S Siena, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapyM Gasparini, L Rottoli, M Massimino, et al.
Tumori|March 1, 1996
[Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation]S Siena, M Bregni, M Di Nicola, et al.
Cancer Research|September 15, 1989
Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin 2: possible role for lymphokine-activated killer cell infusion in the in vivo-induced activationC Gambacorti-Passerini, L Rivoltini, M Radrizzani, et al.
Pageof 5